Skip to main content
OpenTrials

Clinical trial condition

Non-Small Cell Lung Cancer ALK-positive

Explore clinical trials studying Non-Small Cell Lung Cancer ALK-positive. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Non-Small Cell Lung Cancer ALK-positive trial results

Completed

A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

NCT00585195

Conditions
Advanced Malignancies Except Leukemia, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • University of California, Irvine Medical Center Orange, California, United States
  • University of Colorado Hospital/ Anschutz Cancer Pavilion Aurora, Colorado, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • University of Colorado Aurora, Colorado, United States
View all 29 locations
View Trial Details

Related conditions